Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

11.26
-0.0500-0.44%
Post-market: 11.24-0.0200-0.18%19:59 EDT
Volume:4.21M
Turnover:46.40M
Market Cap:2.27B
PE:-53.04
High:11.34
Open:11.17
Low:10.71
Close:11.31
52wk High:15.88
52wk Low:1.39
Shares:201.95M
Float Shares:199.00M
Volume Ratio:0.97
T/O Rate:2.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2123
EPS(LYR):-0.2463
ROE:-39.63%
ROA:-23.30%
PB:16.52
PE(LYR):-45.71

Loading ...

A Look At SELLAS Life Sciences Group (SLS) Valuation After Arbitration And Phase 3 Regal Trial Hopes

Simply Wall St.
·
Jun 09

Sellas Life Sciences gets about $28.7 million from warrant exercises in April-May 2026

Reuters
·
Jun 02

Why SELLAS Life Sciences Group (SLS) Is Up 19.7% After Cramer Endorsement And REGAL Trial Focus

Simply Wall St.
·
Jun 01

Former Sims Bear Questions SLS Earnings Outlook -- Market Talk

Dow Jones
·
Jun 01

Assessing SELLAS Life Sciences Group (SLS) Valuation After Strong Multi-Year Returns And A Sharp One-Day Share Price Drop

Simply Wall St.
·
May 22

SELLAS Life Sciences Group Down Nearly 19%, on Pace for Largest Percent Decrease Since March 2024 -- Data Talk

Dow Jones
·
May 22

SELLAS Life Sciences (SLS) Nears Pivotal AML Data as Cash, Pipeline and ATM Plan Reframe Its Story

Simply Wall St.
·
May 18

Stock Track | SELLAS Life Sciences Soars 5.21% Intraday on Investor Conference Announcements and Positive Growth Coverage

Stock Track
·
May 14

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 14

High Growth Tech Stocks in US for May 2026

Simply Wall St.
·
May 14

Stocks to Watch: NextPower, Sellas, System1, Arteris

Dow Jones
·
May 13

Sellas Life Sciences Shares Climb as Trial Nears Data Review

Dow Jones
·
May 13

SELLAS Life Sciences Gr Q1 EPS $(0.05) Beats $(0.06) Estimate

Benzinga Earnings
·
May 13

SELLAS Life Sciences Group Q1 Loss Narrows

MT Newswires Live
·
May 13

Earnings Flash (SLS) SELLAS Life Sciences Posts Q1 Loss $0.05, vs. FactSet Est of $0.06 Loss

MT Newswires Live
·
May 13

SELLAS Life Sciences Q1 net loss widens on higher expenses

Reuters
·
May 13

BRIEF-SELLAS Life Sciences Q1 Net Income USD -8.407 Million

Reuters
·
May 13

Sellas Life Sciences Q1 Net Income USD -8.407 Million

THOMSON REUTERS
·
May 13

Press Release: SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 13

Sellas Life Sciences Q1 FY26 net loss widens 44.63% to $8.41 million

Reuters
·
May 13